Veda N. Giri, MD

Veda N. Giri, MD, shares key findings from the PROGRESS Registry, which evaluated patient-reported outcomes with prostate cancer genetic testing.

Veda N. Giri, MD, outlines alternative care delivery models that could help improve access to genetic testing for prostate cancer.

Veda N. Giri, MD, outlines some of the key barriers to genetic testing in prostate cancer.

Veda Giri, MD, outlines points of consensus and areas of disagreement across national and international guideline recommendations for germline testing in prostate cancer.

Veda Giri, MD, highlights her recent review publication on the current state of germline testing in prostate cancer.